noom glp 1 reviews consumer reports launches full-page ad in Wall Street Journal advocating for policy changes regarding compounded GLP-1s Noom Review (2026) | Garage

Description

Gastrointestinal (GI) Nausea (most common, especially during the first few weeks)

References 1.Raizada K, Margolin E

As the arsenal of incretin therapies targeting glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors continues to expand, clinicians need to balance the myriad clinical benefits with potentially severe adverse effects (AEs) to put this principle into practice

Glucagon-like peptide-1 receptor agonists in peri-operative care: Dispelling myths and unveiling insights with essential considerations for anaesthesiologists

More than 70% of users report side effects ranging from nausea and bloating to more severe complications like pancreatitis, gallbladder disease, and even mental health concerns such as suicidal ideation or disordered eating